Cargando…
Epigenetic activation of hepatocyte growth factor is associated with epithelial-mesenchymal transition and clinical outcome in non-small cell lung cancer
Hepatocyte growth factor (HGF) expression is repressed in normal differentiated lung epithelial cells, but its expression is aberrantly upregulated in non-small cell lung cancer (NSCLC) and acts as a poor prognostic factor. The underlying molecular mechanisms of aberrant HGF expression are unclear....
Autores principales: | Yin, Jun, Hu, Weimin, Xue, Xingyang, Fu, Wenfan, Dai, Lu, Jiang, Zeyong, Zhong, Shengpeng, Deng, Boyun, Zhao, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775597/ https://www.ncbi.nlm.nih.gov/pubmed/31602259 http://dx.doi.org/10.7150/jca.30034 |
Ejemplares similares
-
HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer
por: Yin, Jun, et al.
Publicado: (2019) -
Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin-resistant non-small cell lung cancer
por: Zhao, Jian, et al.
Publicado: (2020) -
LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer
por: Fu, Wenfan, et al.
Publicado: (2021) -
Cell adhesion molecule 2 (CADM2) promotes brain metastasis by inducing epithelial-mesenchymal transition (EMT) in human non-small cell lung cancer
por: Dai, Lu, et al.
Publicado: (2020) -
let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer
por: Yin, Jun, et al.
Publicado: (2019)